Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
History, Companies, Art & Products
Explore the main themes, entities and connections around Viatris. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
2020 2023 mylan upjohn fda inc healthcare pfizer products company corporation pharmaceuticals pharma famy generics respiratory dermatology 2022 companies 2024
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Viatris | Area served | Worldwide | 1.00 | infobox |
| Viatris | Founded | November 16, 2020; 5 years ago (2020-11-16) | 1.00 | infobox |
| Viatris | Headquarters | Canonsburg, Pennsylvania, U.S. | 1.00 | infobox |
| Viatris | Industry | Pharmaceuticals | 1.00 | infobox |
| Viatris | Industry | Healthcare | 1.00 | infobox |
| Viatris | ISIN | US92556V1061 | 1.00 | infobox |
| Viatris | Key people | Scott A. Smith (CEO) | 1.00 | infobox |
| Viatris | Net income | US$−634 million (2024) | 1.00 | infobox |
| Viatris | Number of employees | c. 32,000 (2024) | 1.00 | infobox |
| Viatris | Operating income | US$10.1 million (2024) | 1.00 | infobox |
| Viatris | Predecessors | Mylan | 1.00 | infobox |
| Viatris | Predecessors | Upjohn | 1.00 | infobox |
| Viatris | Products | Medicines | 1.00 | infobox |
| Viatris | Products | generic drugs | 1.00 | infobox |
| Viatris | Products | biosimilars | 1.00 | infobox |
| Viatris | Products | active pharmaceutical ingredients | 1.00 | infobox |
| Viatris | Revenue | US$14.7 billion (2024) | 1.00 | infobox |
| Viatris | Subsidiaries | Oyster Point Pharma | 1.00 | infobox |
| Viatris | Subsidiaries | Famy Life Sciences | 1.00 | infobox |
| Viatris | Total assets | US$41.5 billion (2024) | 1.00 | infobox |
| Viatris | Total equity | US$18.6 billion (2024) | 1.00 | infobox |
| Viatris | Traded as | Nasdaq: VTRS | 1.00 | infobox |
| Viatris | Traded as | S&P 500 component | 1.00 | infobox |
| Viatris | Type | Public | 1.00 | infobox |
| Viatris | Website | viatris.com | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.